Human and mouse essentiality screens as a resource for disease gene discovery

. 2020 Jan 31 ; 11 (1) : 655. [epub] 20200131

Jazyk angličtina Země Velká Británie, Anglie Médium electronic

Typ dokumentu hodnotící studie, časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid32005800

Grantová podpora
UM1 HG008900 NHGRI NIH HHS - United States
UM1 HG006504 NHGRI NIH HHS - United States
MC_UP_1502/1 Medical Research Council - United Kingdom
UM1 HG006542 NHGRI NIH HHS - United States
UM1 OD023221 NIH HHS - United States
MC_U142684172 Medical Research Council - United Kingdom
UM1 HG006370 NHGRI NIH HHS - United States
UM1 HG006493 NHGRI NIH HHS - United States
U54 HG006370 NHGRI NIH HHS - United States
MC_U142684171 Medical Research Council - United Kingdom
U54 HG006364 NHGRI NIH HHS - United States
UM1 HG006348 NHGRI NIH HHS - United States
U42 OD011174 NIH HHS - United States
U42 OD011175 NIH HHS - United States
Wellcome Trust - United Kingdom
MR/S006753/1 Medical Research Council - United Kingdom

Odkazy

PubMed 32005800
PubMed Central PMC6994715
DOI 10.1038/s41467-020-14284-2
PII: 10.1038/s41467-020-14284-2
Knihovny.cz E-zdroje

The identification of causal variants in sequencing studies remains a considerable challenge that can be partially addressed by new gene-specific knowledge. Here, we integrate measures of how essential a gene is to supporting life, as inferred from viability and phenotyping screens performed on knockout mice by the International Mouse Phenotyping Consortium and essentiality screens carried out on human cell lines. We propose a cross-species gene classification across the Full Spectrum of Intolerance to Loss-of-function (FUSIL) and demonstrate that genes in five mutually exclusive FUSIL categories have differing biological properties. Most notably, Mendelian disease genes, particularly those associated with developmental disorders, are highly overrepresented among genes non-essential for cell survival but required for organism development. After screening developmental disorder cases from three independent disease sequencing consortia, we identify potentially pathogenic variants in genes not previously associated with rare diseases. We therefore propose FUSIL as an efficient approach for disease gene discovery.

Clinical Pharmacology William Harvey Research Institute School of Medicine and Dentistry Queen Mary University of London London EC1M 6BQ UK

Czech Centre for Phenogenomics Institute of Molecular Genetics of the Czech Academy of Sciences Vestec 252 50 Prague Czech Republic

Department of Developmental Genetics Center of Life and Food Sciences Weihenstephan Technische Universität München 85764 Neuherberg Germany

Department of Experimental Genetics Center of Life and Food Sciences Weihenstephan Technische Universität München 85354 Freising Weihenstephan Germany

Department of Genetics Perelman School of Medicine University of Pennsylvania Philadelphia PA 19104 USA

Departments of Molecular and Human Genetics Baylor College of Medicine Houston TX 77030 USA

Departments of Molecular Physiology and Biophysics Baylor College of Medicine Houston TX 77030 USA

Deutsches Institut für Neurodegenerative Erkrankungen Adolf Butenandt Institut Ludwig Maximilians Universität München 80336 Munich Germany

European Molecular Biology Laboratory European Bioinformatics Institute Wellcome Genome Campus Hinxton Cambridge CB10 1SD UK

German Center for Diabetes Research 85764 Neuherberg Germany

German Mouse Clinic Institute of Experimental Genetics Helmholtz Zentrum München German Research Center for Environmental Health 85764 Neuherberg Germany

Institute of Developmental Genetics Helmholtz Zentrum München German Research Center for Environmental Health GmbH 85764 Neuherberg Germany

Medical Research Council Harwell Institute Harwell Oxfordshire OX11 0RD UK

Monterotondo Mouse Clinic Italian National Research Council Institute of Cell Biology and Neurobiology 00015 Monterotondo Scalo Italy

Mouse Biology Program University of California Davis CA 95618 USA

The Centre for Phenogenomics Lunenfeld Tanenbaum Research Institute Mount Sinai Hospital Toronto ON M5T 3H7 Canada

The Centre for Phenogenomics The Hospital for Sick Children Toronto ON M5T 3H7 Canada

The Jackson Laboratory Bar Harbor ME 4609 USA

Translational Medicine The Hospital for Sick Children Toronto ON M5T 3H7 Canada

Université de Strasbourg CNRS INSERM Institut Clinique de la Souris PHENOMIN ICS 67404 Illkirch France

Université de Strasbourg CNRS INSERM Institut de Génétique Biologie Moléculaire et Cellulaire Institut Clinique de la Souris IGBMC PHENOMIN ICS 67404 Illkirch France

Wellcome Trust Sanger Institute Hinxton Cambridge CB10 1SA UK

Zobrazit více v PubMed

Bamshad MJ, et al. The Centers for Mendelian Genomics: a new large-scale initiative to identify the genes underlying rare Mendelian conditions. Am. J. Med. Genet. A. 2012;158a:1523–1525. doi: 10.1002/ajmg.a.35470. PubMed DOI PMC

Deciphering Developmental Disorders Study. Prevalence and architecture of de novo mutations in developmental disorders. Nature. 2017;542:433–438. doi: 10.1038/nature21062. PubMed DOI PMC

Thormann A, et al. Flexible and scalable diagnostic filtering of genomic variants using G2P with Ensembl VEP. Nat. Commun. 2019;10:2373. doi: 10.1038/s41467-019-10016-3. PubMed DOI PMC

Splinter K, et al. Effect of genetic diagnosis on patients with previously undiagnosed disease. N. Engl. J. Med. 2018;379:2131–2139. doi: 10.1056/NEJMoa1714458. PubMed DOI PMC

Petrovski S, Wang Q, Heinzen EL, Allen AS, Goldstein DB. Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet. 2013;9:e1003709. doi: 10.1371/journal.pgen.1003709. PubMed DOI PMC

Lek M, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–291. doi: 10.1038/nature19057. PubMed DOI PMC

Karczewski, K. J. et al. Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. Preprint at https://www.biorxiv.org/content/10.1101/531210v3 (2019). DOI

Kohler S, et al. Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources. Nucleic Acids Res. 2019;47:D1018–D1027. doi: 10.1093/nar/gky1105. PubMed DOI PMC

Westbury SK, et al. Human phenotype ontology annotation and cluster analysis to unravel genetic defects in 707 cases with unexplained bleeding and platelet disorders. Genome Med. 2015;7:36. doi: 10.1186/s13073-015-0151-5. PubMed DOI PMC

Meehan TF, et al. Disease model discovery from 3,328 gene knockouts by the International Mouse Phenotyping Consortium. Nat. Genet. 2017;49:1231–1238. doi: 10.1038/ng.3901. PubMed DOI PMC

Cassa CA, et al. Estimating the selective effects of heterozygous protein-truncating variants from human exome data. Nat. Genet. 2017;49:806–810. doi: 10.1038/ng.3831. PubMed DOI PMC

Luo H, Lin Y, Gao F, Zhang CT, Zhang R. DEG 10, an update of the database of essential genes that includes both protein-coding genes and noncoding genomic elements. Nucleic Acids Res. 2014;42:D574–D580. doi: 10.1093/nar/gkt1131. PubMed DOI PMC

Bartha I, di Iulio J, Venter JC, Telenti A. Human gene essentiality. Nat. Rev. Genet. 2018;19:51–62. doi: 10.1038/nrg.2017.75. PubMed DOI

Chen WH, Lu GT, Chen X, Zhao XM, Bork P. OGEE v2: an update of the online gene essentiality database with special focus on differentially essential genes in human cancer cell lines. Nucleic Acids Res. 2017;45:D940–D944. doi: 10.1093/nar/gkw1013. PubMed DOI PMC

Wang T, et al. Identification and characterization of essential genes in the human genome. Science. 2015;350:1096–1101. doi: 10.1126/science.aac7041. PubMed DOI PMC

Hart T, et al. High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell. 2015;163:1515–1526. doi: 10.1016/j.cell.2015.11.015. PubMed DOI

Blomen VA, et al. Gene essentiality and synthetic lethality in haploid human cells. Science. 2015;350:1092–1096. doi: 10.1126/science.aac7557. PubMed DOI

Munoz-Fuentes V, et al. The International Mouse Phenotyping Consortium (IMPC): a functional catalogue of the mammalian genome that informs conservation. Conserv. Genet. 2018;19:995–1005. doi: 10.1007/s10592-018-1072-9. PubMed DOI PMC

Tsherniak A, et al. Defining a cancer dependency map. Cell. 2017;170:564–576.e16. doi: 10.1016/j.cell.2017.06.010. PubMed DOI PMC

Meyers RM, et al. Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells. Nat. Genet. 2017;49:1779–1784. doi: 10.1038/ng.3984. PubMed DOI PMC

Dickinson ME, et al. High-throughput discovery of novel developmental phenotypes. Nature. 2016;537:508–514. doi: 10.1038/nature19356. PubMed DOI PMC

Brown SDM, et al. High-throughput mouse phenomics for characterizing mammalian gene function. Nat. Rev. Genet. 2018;19:357–370. doi: 10.1038/s41576-018-0005-2. PubMed DOI PMC

Adams D, et al. Bloomsbury report on mouse embryo phenotyping: recommendations from the IMPC workshop on embryonic lethal screening. Dis. Models Mech. 2013;6:571–579. doi: 10.1242/dmm.011833. PubMed DOI PMC

Lin Y, Zhang RR. Putative essential and core-essential genes in Mycoplasma genomes. Sci. Rep. 2011;1:53. doi: 10.1038/srep00053. PubMed DOI PMC

Hart T, Brown KR, Sircoulomb F, Rottapel R, Moffat J. Measuring error rates in genomic perturbation screens: gold standards for human functional genomics. Mol. Syst. Biol. 2014;10:733. doi: 10.15252/msb.20145216. PubMed DOI PMC

Rancati G, Moffat J, Typas A, Pavelka N. Emerging and evolving concepts in gene essentiality. Nat. Rev. Genet. 2018;19:34–49. doi: 10.1038/nrg.2017.74. PubMed DOI

De Kegel B, Ryan CJ. Paralog buffering contributes to the variable essentiality of genes in cancer cell lines. PLoS Genet. 2019;15:e1008466. doi: 10.1371/journal.pgen.1008466. PubMed DOI PMC

Spataro N, Rodriguez JA, Navarro A, Bosch E. Properties of human disease genes and the role of genes linked to Mendelian disorders in complex disease aetiology. Hum. Mol. Genet. 2017;26:489–500. PubMed PMC

Georgi B, Voight BF, Bucan M. From mouse to human: evolutionary genomics analysis of human orthologs of essential genes. PLoS Genet. 2013;9:e1003484. doi: 10.1371/journal.pgen.1003484. PubMed DOI PMC

Han SK, Kim I, Hwang J, Kim S. Network modules of the cross-species genotype-phenotype map reflect the clinical severity of human diseases. PLoS ONE. 2015;10:e0136300. doi: 10.1371/journal.pone.0136300. PubMed DOI PMC

Turnbull C, et al. The 100 000 Genomes Project: bringing whole genome sequencing to the NHS. BMJ. 2018;361:k1687. doi: 10.1136/bmj.k1687. PubMed DOI

Ji X, Kember RL, Brown CD, Bucan M. Increased burden of deleterious variants in essential genes in autism spectrum disorder. Proc. Natl Acad. Sci. USA. 2016;113:15054–15059. doi: 10.1073/pnas.1613195113. PubMed DOI PMC

Dawes R, Lek M, Cooper ST. Gene discovery informatics toolkit defines candidate genes for unexplained infertility and prenatal or infantile mortality. NPJ Genom. Med. 2019;4:8. doi: 10.1038/s41525-019-0081-z. PubMed DOI PMC

Hussin JG, et al. Recombination affects accumulation of damaging and disease-associated mutations in human populations. Nat. Genet. 2015;47:400–404. doi: 10.1038/ng.3216. PubMed DOI

Zhang, X., Acencio, M. L. & Lemke, N. Predicting essential genes and proteins based on machine learning and network topological features: a comprehensive review. Front. Physiol.7, 75 (2016). PubMed PMC

Dickerson JE, Zhu A, Robertson DL, Hentges KE. Defining the role of essential genes in human disease. PLoS ONE. 2011;6:e27368. doi: 10.1371/journal.pone.0027368. PubMed DOI PMC

Martin HC, et al. Quantifying the contribution of recessive coding variation to developmental disorders. Science. 2018;362:1161–1164. doi: 10.1126/science.aar6731. PubMed DOI PMC

Lord J, et al. Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study. Lancet. 2019;393:747–757. doi: 10.1016/S0140-6736(18)31940-8. PubMed DOI PMC

Posey JE, et al. Insights into genetics, human biology and disease gleaned from family based genomic studies. Genet. Med. 2019;21:798–812. doi: 10.1038/s41436-018-0408-7. PubMed DOI PMC

Turner TN, et al. denovo-db: a compendium of human de novo variants. Nucleic Acids Res. 2017;45:D804–D811. doi: 10.1093/nar/gkw865. PubMed DOI PMC

Stuchell-Brereton MD, et al. ESCRT-III recognition by VPS4 ATPases. Nature. 2007;449:740–744. doi: 10.1038/nature06172. PubMed DOI

Mohun T, et al. Deciphering the Mechanisms of Developmental Disorders (DMDD): a new programme for phenotyping embryonic lethal mice. Dis. Models Mech. 2013;6:562–566. doi: 10.1242/dmm.011957. PubMed DOI PMC

Clark MM, et al. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases. NPJ Genom. Med. 2018;3:16. doi: 10.1038/s41525-018-0053-8. PubMed DOI PMC

Eilbeck K, Quinlan A, Yandell M. Settling the score: variant prioritization and Mendelian disease. Nat. Rev. Genet. 2017;18:599–612. doi: 10.1038/nrg.2017.52. PubMed DOI PMC

Pengelly RJ, Vergara-Lope A, Alyousfi D, Jabalameli MR, Collins A. Understanding the disease genome: gene essentiality and the interplay of selection, recombination and mutation. Brief. Bioinformatics. 2019;20:267–273. doi: 10.1093/bib/bbx110. PubMed DOI

Gu ZL, et al. Role of duplicate genes in genetic robustness against null mutations. Nature. 2003;421:63–66. doi: 10.1038/nature01198. PubMed DOI

Eyre-Walker YC, Eyre-Walker A. The role of mutation rate variation and genetic diversity in the architecture of human disease. PLoS ONE. 2014;9:e90166. doi: 10.1371/journal.pone.0090166. PubMed DOI PMC

Fuller ZL, Berg JJ, Mostafavi H, Sella G, Przeworski M. Measuring intolerance to mutation in human genetics. Nat. Genet. 2019;51:772–776. doi: 10.1038/s41588-019-0383-1. PubMed DOI PMC

Robinson PN, et al. Improved exome prioritization of disease genes through cross-species phenotype comparison. Genome Res. 2014;24:340–348. doi: 10.1101/gr.160325.113. PubMed DOI PMC

Bojanowski, M. & Edwards, R. alluvial: R Package for Creating Alluvial Diagrams. R Package Version 0.1-2 (Bioconductor, 2016).

Gentleman, R. Category: Category Analysis. R Package Version 2.48.1 (Bioconductor, 2019).

Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Stat. Methodol. 1995;57:289–300.

Supek F, Bosnjak M, Skunca N, Smuc T. REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS ONE. 2011;6:e21800. doi: 10.1371/journal.pone.0021800. PubMed DOI PMC

Yu G, He Q-Y. ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization. Mol. Biosyst. 2016;12:477–479. doi: 10.1039/C5MB00663E. PubMed DOI

Smith CL, et al. Mouse Genome Database (MGD)-2018: knowledgebase for the laboratory mouse. Nucleic Acids Res. 2018;46:D836–D842. doi: 10.1093/nar/gkx1006. PubMed DOI PMC

Cummings, B. B. et al. Transcript expression-aware annotation improves rare variant discovery and interpretation. Preprint at https://www.biorxiv.org/content/10.1101/554444v1 (2019). PubMed DOI PMC

Huang N, Lee I, Marcotte EM, Hurles ME. Characterising and predicting haploinsufficiency in the human genome. PLoS Genet. 2010;6:e1001154. doi: 10.1371/journal.pgen.1001154. PubMed DOI PMC

Halldorsson, B. V. et al. Characterizing mutagenic effects of recombination through a sequence-level genetic map. Science363, eaau1043 (2019). PubMed

Lawrence, M. HelloRanges: Introduce *Ranges to Bedtools Users. R Package Version 1.8.0 (Bioconductor, 2018).

Durinck S, Spellman PT, Birney E, Huber W. Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt. Nat. Protoc. 2009;4:1184–1191. doi: 10.1038/nprot.2009.97. PubMed DOI PMC

Battle A, Brown CD, Engelhardt BE, Montgomery SB. Genetic effects on gene expression across human tissues. Nature. 2017;550:204–213. doi: 10.1038/nature24277. PubMed DOI PMC

Szklarczyk D, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447–D452. doi: 10.1093/nar/gku1003. PubMed DOI PMC

Assenov Y, Ramirez F, Schelhorn SE, Lengauer T, Albrecht M. Computing topological parameters of biological networks. Bioinformatics. 2008;24:282–284. doi: 10.1093/bioinformatics/btm554. PubMed DOI

Giurgiu M, et al. CORUM: the comprehensive resource of mammalian protein complexes-2019. Nucleic Acids Res. 2019;47:D559–D563. doi: 10.1093/nar/gky973. PubMed DOI PMC

Samocha KE, et al. A framework for the interpretation of de novo mutation in human disease. Nat. Genet. 2014;46:944–950. doi: 10.1038/ng.3050. PubMed DOI PMC

Sampson MG, Gillies CE, Ju W, Kretzler M, Kang HM. Gene-level integrated metric of negative selection (GIMS) prioritizes candidate genes for nephrotic syndrome. PLoS ONE. 2013;8:e81062. doi: 10.1371/journal.pone.0081062. PubMed DOI PMC

Smedley, D. et al. PhenoDigm: analyzing curated annotations to associate animal models with human diseases. Database (Oxford)2013, bat025 (2013). PubMed PMC

Kirkpatrick BE, et al. GenomeConnect: matchmaking between patients, clinical laboratories, and researchers to improve genomic knowledge. Hum. Mutat. 2015;36:974–978. doi: 10.1002/humu.22838. PubMed DOI PMC

Fabregat A, et al. The Reactome Pathway Knowledgebase. Nucleic Acids Res. 2018;46:D649–D655. doi: 10.1093/nar/gkx1132. PubMed DOI PMC

Miller JA, et al. Transcriptional landscape of the prenatal human brain. Nature. 2014;508:199–206. doi: 10.1038/nature13185. PubMed DOI PMC

Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 2017;8:1826. doi: 10.1038/s41467-017-01261-5. PubMed DOI PMC

R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, 2018).

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...